Related references
Note: Only part of the references are listed.Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction
Shigeru Matsui et al.
ATHEROSCLEROSIS (2010)
Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome
Onkar S. Dhillon et al.
CLINICAL SCIENCE (2010)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome
Sohail Q. Khan et al.
CLINICAL SCIENCE (2009)
HEART FATTY ACID BINDING PROTEIN FOR RAPID DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN THE EMERGENCY DEPARTMENT
Rick Body et al.
EMERGENCY MEDICINE JOURNAL (2009)
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Sohail Q. Khan et al.
EUROPEAN HEART JOURNAL (2009)
Improving the Diagnosis of Acute Heart Failure Using a Validated Prediction Model
Brian Steinhart et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Tobias Reichlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction.
Till Keller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study
L. Lorgis et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S. Sabatine et al.
CIRCULATION (2008)
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: Preliminary observations from the IFCC committee for standardization of markers of cardiac damage
Kristin N. Luckenbill et al.
CLINICAL CHEMISTRY (2008)
Circulating Stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction
D. Kelly et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction
S. Q. Khan et al.
HEART (2008)
C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial Infarction
Dominic Kelly et al.
JOURNAL OF CARDIAC FAILURE (2008)
Serum Soluble ST2 as a Biochemical Marker of Acute Heart Failure Future Areas of Research
Javier Diez
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: Comparison with plasma midregional pro-atrial natriuretic peptide - the LAMP (Leicester Acute Myocardial Infarction Peptide) study
Sohail Q. Khan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
Tibor Kempf et al.
EUROPEAN HEART JOURNAL (2007)
Universal definition of myocardial infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values
Niamh Kilcullen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study
Sohail Q. Khan et al.
AMERICAN HEART JOURNAL (2007)
Serum Myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals - The EPIC-Norfolk prospective population study
Marijn C. Meuwese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction
Sohail Q. Khan et al.
HEART (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction
Tessa J. Mocatta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study
Sohail Q. Khan et al.
CIRCULATION (2007)
Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction
Sohail Q. Khan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study
Dominic Kelly et al.
EUROPEAN HEART JOURNAL (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Copeptin and arginine vasopressin concentrations in critically ill patients
Stefan Jochberger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes
Michelle O'Donoghue et al.
CIRCULATION (2006)
Biomarkers of cardiovascular disease - Molecular basis and practical considerations
Ramachandran S. Vasan
CIRCULATION (2006)
Aquaretic efect of Lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients
WT Abraham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction - Predictive role of C-reactive protein
M Suleiman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure
J Wang et al.
CIRCULATION RESEARCH (2005)
TIMI, PURSUIT, and GRACE risk scores:: sustained prognostic value and interaction with revascularization in NSTE-ACS
PDA Gonçalves et al.
EUROPEAN HEART JOURNAL (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A superior early myocardial infarction marker - Human heart-type fatty acid-binding protein
CPY Chan et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2004)
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial
M Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus
K Itoi et al.
JOURNAL OF NEUROENDOCRINOLOGY (2004)
N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction
IB Squire et al.
CLINICAL SCIENCE (2004)
Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides
M Ala-Kopsala et al.
CLINICAL CHEMISTRY (2004)
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NTproBNP) in frozen plasma samples
T Mueller et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Immunoluminometric assay for the midregion of pro-Atrial natriuretic peptide in human plasma
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2004)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes
O Bazzino et al.
EUROPEAN HEART JOURNAL (2004)
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease
T Jernberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation
J Lund et al.
CIRCULATION (2003)
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
S Baldus et al.
CIRCULATION (2003)
Using C-reactive protein to assess cardiovascular disease risk
MH Shishehbor et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2003)
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarttion - B-Type natriuretic peptide and prognosis in TACTICS-TIMI 18
DA Morrow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells
S Devaraj et al.
CIRCULATION (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Serum plasma pregnancy-associated protein A - A potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk
JL Beaudeux et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Neutrophil infiltration of culprit lesions in acute coronary syndromes
T Naruko et al.
CIRCULATION (2002)
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes
T Omland et al.
CIRCULATION (2002)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)
Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis
LS Laursen et al.
BIOCHEMICAL JOURNAL (2002)
A self-fulfilling prophecy - C-reactive protein attenuates nitric oxide production and inhibits angiogenesis
S Verma et al.
CIRCULATION (2002)
Validation of the thrombolysis in myocardial infarction (TIMI) risk sore for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry
BM Scirica et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Widespread coronary inflammation in unstable angina
A Buffon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes - Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
MS Sabatine et al.
CIRCULATION (2002)
T-cell-mediated lysis of endothelial cells in acute coronary syndromes
T Nakajima et al.
CIRCULATION (2002)
Association between myeloperoxidase levels and risk of coronary artery disease
ZL Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pregnancy-associated plasma protein a as a marker of acute coronary syndromes
A Bayes-Genis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA de Lemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation
K Oshikawa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Identification of human ST2 protein in the sera of patients with autoimmune diseases
K Kuroiwa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients
E Boersma et al.
CIRCULATION (2000)
Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein -: Relationship with age, sex, and hormone replacement treatment
A Nakagomi et al.
CIRCULATION (2000)
Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations
H Tunstall-Pedoe et al.
LANCET (2000)
The insulin-like growth factor axis - A review of atherosclerosis and restenosis
A Bayes-Genis et al.
CIRCULATION RESEARCH (2000)
Share Paper
